New strategy aims to boost HIV viral suppression in young people
NCT ID NCT06886971
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a program called SAVVY that helps young people with HIV choose their preferred antiretroviral therapy (ART) and overcome barriers to getting it. The program includes counseling and a decision-support tool. Researchers will enroll 288 participants to see if this approach increases the number who achieve viral suppression (HIV levels below 20 copies/mL).
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- behavioral intervention (CHOICE counseling and HIV-ASSIST decision-support tool)
- What this could lead to
- If successful, this approach could help more young people with HIV achieve and maintain viral suppression, reducing individual and public health risks.
- What could go wrong
- This is an early-stage behavioral study with no direct drug testing; results may not generalize to all youth or settings, and viral suppression depends on many factors beyond the intervention.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Johns Hopkins University
RECRUITINGBaltimore, Maryland, 21287, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.